Latest News for: glp

Edit

Lisa Jarvis: The knockoff GLP-1 market is still the Wild West

Image News & Record 12 Feb 2026
Telehealth company Hims & Hers unleashed a wild few days in the obesity drug market last week when it introduced a cheap, compounded version of Novo Nordisk’s new Wegovy pill ... .
Edit

Knockoff GLP-1 market still the Wild West

Image Waco Tribune-Herald 12 Feb 2026
Telehealth company Hims & Hers unleashed a wild few days in the obesity drug market last week when it introduced a cheap, compounded version of Novo Nordisk's new Wegovy pill. It was an audacious attempt for a piece of the ....
Edit

Using GLP-1s to maintain a normal weight? There are benefits and risks

National Public Radio 12 Feb 2026
Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric surgery to keep pounds from creeping back. Others may just want to lose a few pounds. (Image credit. Christie Woodard) ....
Edit

GLP-1 pill offers new weight-loss option

Observer-Reporter 12 Feb 2026
Food and Drug Administration (FDA) recently approved a daily pill form of Wegovy, making it the first oral GLP-1 available on the market for weight loss ... And Wegovy may not be the only GLP-1 drug available in pill form for long.
Edit

McDonald's execs are figuring out how to handle more customers on GLP-1s

Business Insider 12 Feb 2026
McDonald's is evaluating how to handle more customers on GLP-1 drugs ... In a Wednesday earnings call, McDonald's executives talked about how the chain was testing menu items for more customers on GLP-1s ... GLP-1 adoption in the US is on the rise.
Edit

Exploring the Long-Term Impact of GLP-1 Weight-Loss Drugs: Are They the Solution?

Gulf News 12 Feb 2026
GLP-1 drugs such as Wegovy and Mounjaro are no longer just diabetes medications but have become symbols of hope for millions of people struggling with obesity ... GLP-1 therapies were not originally designed for weight loss.
Edit

Jarvis: The knockoff GLP-1 market is still the Wild West

The Mercury News 12 Feb 2026
It was an audacious attempt for a piece of the lucrative GLP-1 market that came to a swift and disastrous end — the company pulled its product just two days after its launch after U.S ... 1 rule with compounded GLP-1s in the U.S.
Edit

Are GLP-1 weight-loss drugs really rewriting Denver restaurant menus? | Opinion

Denver Post 12 Feb 2026
GLP-1s, drugs designed to regulate blood sugar, weren’t supposed to disrupt how we eat ... Over the past couple of years, as millions of Americans began taking these GLP-1s — and as appetites have shrunk — restaurants started to notice.
Edit

Legal pressures mount for Hims & Hers over GLP-1 sales

The Hill 11 Feb 2026
... major drugmaker due to its sale of popular compounded GLP-1 medications.
Edit

Comedian Aishwarya Mohanraj admits using Mounjaro—Who should take GLP-1?

India Today 11 Feb 2026
Comedian Aishwarya Mohanraj admits using MounjaroWho should take GLP ... .
Edit

Edible Garden to Introduce Clean-Label JEALOUSY GLP-1 Support System and New Kick. Sports Nutrition� Innovations ...

Nasdaq Globe Newswire 11 Feb 2026
Expands Wellness Platform with Targeted GLP-1 Support Products Focused on Fiber, Vitality, and Protein ... .
Edit

The Truth About GLP-1 for Weight loss & Why We Don’t Recommend

Rumble 11 Feb 2026
Click the Rumble article link to see the video ....
Edit

Taking GLP-1 Drugs May Put You at Risk of Rare ‘Pirate Disease’

The Daily Beast 11 Feb 2026
As GLP-1 weight-loss drugs soar in popularity, the list of unfortunate side effects that accompany them grows ...
Edit

Eccogene Announces Positive Topline Results from Phase 1b Trial of Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 ...

Business Wire 11 Feb 2026
SHANGHAI & BOSTON--(BUSINESS WIRE)--Eccogene Announces Positive Topline Results from Phase 1b Trial in China of Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 Receptor Agonist ... .
Edit

Cut to GLP-1 coverage prevents personnel cuts this year, but fiscal challenges ahead for Chelmsford

Boston Herald 11 Feb 2026
Cohen said he had been bracing for another sharp spike in health insurance premium costs, to the tune of about 13%, but that figure was able to be dropped to 8% thanks to a cut to coverage for GLP-1 drugs.

Article Search

tools
×
×
×
×